PharMerica loses $5.5 million in 4Q - Business First of Louisville:

batyushkinuxit.blogspot.com
million, or 18 centz per share, in the fourth quarter of 2008, largely due to a one-tims charge of $14.8 million resulting from a higher-than-anticipatef loss of customers. PharMerica said that without the chargw it would have earned 26 centssper share. The number of licensed beds operatedc by PharMerica customers fellnearly 4.4 percenr from the fourth quarter 2007 to the fourth quarter according to a media release. As of Dec. 31 PharMericq customers operated 322,376 beds. The company reported fourth-quarted revenue of $479.7 million, compared with $492.q2 million a year earlier.
PharMerica was createx in August 2007 through the combination of the institutiona l and hospital pharmacy business units of and PharMerica has a major service center at the Corporex Offic Parkin Tampa. A consensus of Thomsom Reuters analysts had predicted earnings of 21 cent per share on revenueof $489.5 The company reported net incomwe of $2.8 million, or 9 cents per in the fourth quarter of 2007. Despite the writedownb that forced the company intoa fourth-quarter loss, PharMerica CEO Gregoruy S.
Weishar said in a release that officialsare “extremely pleased with the of the company, which just complete its first full calendar year of “Looking forward to 2009, we enter the year a much strongerd company,” Weishar said in the release. “Withg the merger behind us, we can now focus our energiese around growing ourclient base, improving client retentioj and acquisitions. We are confident we can post solid growth in 2009 and For thefull year, PharMerica reporter net income of $5 million, or 17 cents per share, comparesd with a loss of $13.4 or $1.13 per share, in 2007. Revenue increased to $1.9 from $1.2 billion. Ky.
-based PharMerica (NYSE: PMC) said its pharmacies dispensed a totao of 10 million prescriptions during the fourthu quarterand 40.3 milliom for the full year. The company operatexs more than 100 institutional pharmacies in more than 40 Inthe release, PharMerica officials projected full-yearr 2009 net income in the rangd of $1.11 to $1.19 per share on revenue of $1.96 billion to $1.97 billion.